{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:55:30Z","timestamp":1768679730449,"version":"3.49.0"},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,5,1]]},"DOI":"10.2169\/internalmedicine.9835-17","type":"journal-article","created":{"date-parts":[[2017,12,26]],"date-time":"2017-12-26T22:16:15Z","timestamp":1514326575000},"page":"1191-1200","source":"Crossref","is-referenced-by-count":18,"title":["An Evaluation of Clinical Economics and Cases of Cost-effectiveness"],"prefix":"10.2169","volume":"57","author":[{"given":"Tomoyuki","family":"Takura","sequence":"first","affiliation":[{"name":"Department of Healthcare Economics and Health Policy, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Takura T. [The appropriate state of Cost-effectiveness evaluation in Medicine in Japan]. In: Iryou Hakusho 2016-2017 (White paper of Medicine 2016-2017). Nihon Iryou Kikaku, Tokyo, 2016: 160-169 (in Japanese)."},{"key":"2","unstructured":"2. [Dilemma of expensive new drugs - high efficacy, and hopes for patients, but the cost of 2.6 million Yen per month may make the insurance system fall into crisis]. Yomiuri Shimbun; morning issue: 6, May 24, 2016 (in Japanese)."},{"key":"3","unstructured":"3. [An interim report of discussion for the test run of Cost-effective evaluation]. Paper presented at Chuou Shakai Hoken Iryou Hyougikai Hiyou Tai Kouka Senmon Bukai; August 26, 2015 (in Japanese); Tokyo [Internet] [cited 2017 Jul 11]. Available from: http:\/\/www.mhlw.go.jp\/file\/05-Shingikai-12404000-Hokenkyoku-Iryouka\/0000095706.pdf"},{"key":"4","unstructured":"4. Takura T. Iryou Keizai (83) (Healthcare economics). Intervention Hikkei (Intervention Handbook -a handbook for Medical Specialists-). Japanese Association of Cardiovascular Intervention and Therapeutics, Tokyo, 2013: 215-219 (in Japanese)."},{"key":"5","unstructured":"5. Takura T. [The Value, and the appropriate state of reward of Nursing art]. In: Kango Keiei\/Keizai Ron (Administration and Economic theory in Nursing). Kanai-Pak M, Ed. Japanese Nursing Association Publishing Company, Tokyo, 2011: 150-161 (in Japanese)."},{"key":"6","unstructured":"6. Takura T. [Hospital Management must be changed too, the changing markets\/establishing the presence in the markets\/responsibility to have conversation with markets]. Hoken Shinryo (Journal of Health Insurance & Medical Practice) 59: 374-375, 2005 (in Japanese)."},{"key":"7","unstructured":"7. Takura T. [Contact Lenses' medical practice and health economics]. Nihon Contact Lens Gakkai Shi (Journal of Japan Contact Lens Society) 51: 204-209, 2009 (in Japanese)."},{"key":"8","unstructured":"8. Takura T. [Creating new value in medical care -methodology of social evaluation of medical technologies]. Iyaku Keizai (Journal of Pharmaceutical Business) 1339: 16-17, 2009 (in Japanese)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Anderson JL, Heidenreich PA, Barnett PG, et al. ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures. JACC 63: 2304-2322, 2014.","DOI":"10.1016\/j.jacc.2014.03.016"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. JCS Joint Working Group. Guidelines for rehabilitation in patients with cardiovascular disease (JCS 2012). Jpn Circ J 78: 2022-2093, 2014.","DOI":"10.1253\/circj.CJ-66-0094"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Klarman HE. Present status of cost-benefit analysis in the health field. Am J Public Health Nations Health 7: 1948-1953, 1967.","DOI":"10.2105\/AJPH.57.11.1948"},{"key":"12","unstructured":"12. Takura T. [Making the socioeconomic value of hemodialysis visible]. In: Zenjinryoku\/Kagakuryoku\/Tousekiryoku for the people - Touseki igaku (The power of Human\/Science\/Hemodialysis for the people - Hemodialysis practice). Hirakata H, Ed. Medicine and Drug Journal, Tokyo, 2014: 286-290 (in Japanese)."},{"key":"13","unstructured":"13. Takura T. [Decision process of Medical treatment fees in Japan and its legitimacy - performance analysis and optimize tool conception]. Sougou Rinshou (Clinic All-Round) 56: 3259-3265, 2007 (in Japanese)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Takura T, Nakanishi T, Kawanishi H, et al. Cost-effectiveness of maintenance hemodialysis in Japan. Ther Apher Dial 19: 441-449, 2015.","DOI":"10.1111\/1744-9987.12314"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Benz K, D\u00f6tsch J, Rascher W, Stachel D. Changes of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 19: 794-797, 2004.","DOI":"10.1007\/s00467-004-1434-z"},{"key":"16","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","volume":"384","author":"K Iijima","year":"2014","unstructured":"16. Iijima K, Sako M, Nozu K, et al. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384: 1273-1281, 2014.","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"17","first-page":"7","author":"T Takura","year":"2017","unstructured":"17. Takura T, Takei T, Nitta K. Cost-effectiveness of administering rituximab for steroid-dependent nephrotic syndrome and frequently relapsing nephrotic syndrome: a preliminary study in Japan. Scientific Reports 7, Article number: 46036, 2017.","journal-title":"Scientific Reports","ISSN":"https:\/\/id.crossref.org\/issn\/2045-2322","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/9\/57_9835-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,5]],"date-time":"2018-05-05T03:34:22Z","timestamp":1525491262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/9\/57_9835-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9835-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,1]]}}}